The FDA has recently announced that they will be changing regulations pertaining to drug labeling for pregnant woman. In particular, there will be a new system with the first of three parts of a physician update focusing particularly on birth defects. We can’t help but think that these changes have come too later for many of our Zofran clients but better late than never. This is the first time regulators have updated their pregnancy warning system since 1979. Hopefully, this new criteria will aid in making sure that doctors receive full disclosure and all information in assessing the risks and benefits of prescribing drugs to pregnant woman.
READ the full article HERE